CoreFirst Bank & Trust’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $112K | Buy |
+894
| New | +$112K | 0.06% | 152 |
|
|
2025
Q1 | – | Sell |
-304
| Closed | -$46.5K | – | 136 |
|
|
2024
Q4 | $46.5K | Hold |
304
| – | – | 0.03% | 222 |
|
|
2024
Q3 | $58.9K | Buy |
+304
| New | +$58.9K | 0.03% | 207 |
|
|
2024
Q2 | – | Sell |
-304
| Closed | -$65.6K | – | 147 |
|
|
2024
Q1 | $65.6K | Hold |
304
| – | – | 0.04% | 197 |
|
|
2023
Q4 | $78.7K | Hold |
304
| – | – | 0.05% | 185 |
|
|
2023
Q3 | $78.1K | Hold |
304
| – | – | 0.06% | 189 |
|
|
2023
Q2 | $86.6K | Hold |
304
| – | – | 0.06% | 178 |
|
|
2023
Q1 | $84.5K | Hold |
304
| – | – | 0.06% | 176 |
|
|
2022
Q4 | $84.2K | Hold |
304
| – | – | 0.06% | 190 |
|
|
2022
Q3 | $81K | Hold |
304
| – | – | 0.07% | 175 |
|
|
2022
Q2 | $62K | Sell |
304
-200
| -40% | -$40.8K | 0.05% | 192 |
|
|
2022
Q1 | $106K | Buy |
504
+304
| +152% | +$63.9K | 0.07% | 170 |
|
|
2021
Q4 | $48K | Sell |
200
-250
| -56% | -$60K | 0.03% | 257 |
|
|
2021
Q3 | $127K | Hold |
450
| – | – | 0.09% | 162 |
|
|
2021
Q2 | $156K | Hold |
450
| – | – | 0.11% | 151 |
|
|
2021
Q1 | $126K | Hold |
450
| – | – | 0.09% | 163 |
|
|
2020
Q4 | $110K | Buy |
+450
| New | +$110K | 0.08% | 160 |
|